<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04194385</url>
  </required_header>
  <id_info>
    <org_study_id>71306642-050-05-04-</org_study_id>
    <nct_id>NCT04194385</nct_id>
  </id_info>
  <brief_title>Upper Trunk Block Versus Costoclavicular Block For Arthroscopic Shoulder Surgery</brief_title>
  <official_title>Comparison of Perioperative Analgesic Efficacy of Ultrasonography Guided Upper Trunk Block and Costoclavicular Infraclavicular Brachial Plexus Block in Arthroscopic Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interscalene brachial plexus block is known as the gold standard for analgesia after shoulder&#xD;
      surgery, but limits the use of ipsilateral phrenic nerve paralysis. Recently, interest in&#xD;
      potential diaphragm-sparing alternative blocks has increased for patients undergoing shoulder&#xD;
      surgery.Two of these blocks are upper trunk block (UTB) and costoclavicular brachial plexus&#xD;
      (CCBPB) block. This randomized controlled trial will compare ultrasound-guided UTB and CCBPB&#xD;
      in patients undergoing arthroscopic shoulder surgery.&#xD;
&#xD;
      The main outcome is pain intensity score at 30 minutes after arrival in the post anesthesia&#xD;
      care unit (PACU) as measured by a numerical rating scale (NRS) from 0 to 10. The&#xD;
      investigators research hypothesis is that UTB and CCBPB will result in equivalent&#xD;
      postoperative analgesia at 30 minutes in the PACU.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity score</measure>
    <time_frame>30 minutes after the surgery completion</time_frame>
    <description>Postoperative pain assessed with verbal rating scale (VRS 0: no pain 10:pain as bad as can be ) at 30 minute postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>Total amount of tramadol consumption during the first 24 hours after surgery. Patient controlled analgesia to be inserted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block perform time</measure>
    <time_frame>The time from the needle enters the skin until the block is completed</time_frame>
    <description>Block application time will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block onset time</measure>
    <time_frame>Until sensory and motor block occurs</time_frame>
    <description>Block onset time will be evaluated and recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of diaphragmatic paralysis by ultrasonography</measure>
    <time_frame>30 minutes after block application</time_frame>
    <description>Ipsilateral diaphragmatic excursion 30 minutes after block completion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory and Motor block score</measure>
    <time_frame>5, 10,20,30 minutes after block application</time_frame>
    <description>Sensorimotor block assessed every 5 minutes until 30 minutes using a 3-point score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl requirement</measure>
    <time_frame>From the beginning to the end of the operation</time_frame>
    <description>During the operation, 0.5 μg/kg fentanyl was administered to the patient in case of a 20% increase in the mean blood pressure and heart rate compared to the baseline values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity score</measure>
    <time_frame>30 minutes, 1,3, 6, 12, 24 hour after surgery</time_frame>
    <description>Postoperative pain assessed with verbal rating scale (VRS 0: no pain 10:pain as bad as can be )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction: NRS</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>Patient satisfaction measured using a NRS 0 to 10 (0 = unsatisfied; 10 =very satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Shoulder Pain</condition>
  <condition>Phrenic Nerve Paralysis</condition>
  <arm_group>
    <arm_group_label>Upper trunk block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the supraclavicular region, UTB will be applied with 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Costoclavicular brachial plexus block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the infraclavicular region, CCBPB will be applied with 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Upper trunk block</intervention_name>
    <description>Block will be applied to supraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine .</description>
    <arm_group_label>Upper trunk block</arm_group_label>
    <other_name>Upper trunk brachial plexus block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Costoclavicular block</intervention_name>
    <description>Block will be applied to infraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.</description>
    <arm_group_label>Costoclavicular brachial plexus block</arm_group_label>
    <other_name>Costoclavicular brachial plexus block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Diaphragmatic function assessment</intervention_name>
    <description>Diaphragmatic excursion will be assessed under ultrasound immediately before and after regional anesthesia.</description>
    <arm_group_label>Costoclavicular brachial plexus block</arm_group_label>
    <arm_group_label>Upper trunk block</arm_group_label>
    <other_name>Detection of diaphragmatic paralysis with ultrasound guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cervical plexus blockade</intervention_name>
    <description>Block will be applied at thyroid cartilage level via 10 ml % 0.25 bupivacaine.</description>
    <arm_group_label>Costoclavicular brachial plexus block</arm_group_label>
    <arm_group_label>Upper trunk block</arm_group_label>
    <other_name>Superficial cervical plexus blockade</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. American Association of Anesthesiologists (ASA) physical status I - III&#xD;
&#xD;
          2. BMI 20 to 35 kg / m2&#xD;
&#xD;
          3. Patients scheduled for elective arthroscopic shoulder surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who refuse to participate in the study,&#xD;
&#xD;
          2. Pre-existing (obstructive or restrictive) lung disease,&#xD;
&#xD;
          3. Coagulopathy,&#xD;
&#xD;
          4. Sepsis,&#xD;
&#xD;
          5. Hepatic or renal insufficiency,&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
          7. Allergy to local anesthetic drugs,&#xD;
&#xD;
          8. Chronic pain condition requiring opioid intake at home,&#xD;
&#xD;
          9. Surgery in the neck or infraclavicular region&#xD;
&#xD;
         10. BMI above 40.&#xD;
&#xD;
         11. History of psychiatric diseases needing treatment.&#xD;
&#xD;
         12. Failure of nerve block performed in the preoperative block room&#xD;
&#xD;
         13. Substance abuse history&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serdar Yeşiltaş, Instructor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bezmialem Vakif University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serdar Yeşiltaş, Instructor</last_name>
    <phone>+90 542 363 26 30</phone>
    <email>syesiltas@bezmialem.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bezmialem Vakıf University</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serdar Yeşiltaş, Assist.Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2019</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bupivacaine</keyword>
  <keyword>costoclavicular block</keyword>
  <keyword>upper trunk block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

